HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$1.14
Day range
$1.12 - $1.18
Year range
$0.78 - $2.48
Market cap
241.04M USD
Avg Volume
3.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 32.61M | -18.74% |
Operating expense | 44.18M | 29.06% |
Net income | -17.98M | 31.40% |
Net profit margin | -55.16 | 15.57% |
Earnings per share | -0.08 | 40.34% |
EBITDA | -5.50M | 63.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 41.96M | -26.32% |
Total assets | 225.48M | -18.56% |
Total liabilities | 252.74M | -13.21% |
Total equity | -27.26M | — |
Shares outstanding | 209.60M | — |
Price to book | -8.77 | — |
Return on assets | -15.92% | — |
Return on capital | -54.05% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.98M | 31.40% |
Cash from operations | -19.43M | -10.80% |
Cash from investing | — | — |
Cash from financing | 18.48M | 215.71% |
Net change in cash | -957.00K | 97.14% |
Free cash flow | -6.59M | 16.83% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
167